Assignee
GUANGZHOU VIROTECH PHARMACEUTICAL CO LTD
CN·5 granted patents·4 pending applications·2 citations·filing 2015–2020
Top patents by PatentIndex Score
9 records- 0175US11234968B2Use of VCP inhibitor and oncolytic virus in the preparation of an anti-tumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2017·Granted Feb 1, 2022·1 cites·12 claims
- 0268US10517909B2Use of alphavirus in preparation of antitumor drugsGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2015·Granted Dec 31, 2019·1 cites·45 claims
- 0358US11235011B2Use of alphavirus in preparation of antitumor drugsGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2019·Granted Feb 1, 2022·0 cites·20 claims
- 0453US10980850B2Use of IAP inhibitor and oncolytic virus in preparation of anti-tumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2017·Granted Apr 20, 2021·0 cites·13 claims
- 0547US12529037B2M1 virus mutant and use thereofGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2020·Granted Jan 20, 2026·0 cites·19 claims
- 0646US2021228660A1Use of proteasome inhibitor and alphavirus in preparation of anti-tumor medicamentGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 0743US2020405793A1Use of mevalonate metabolic pathway inhibitor and alphavirus in preparing anti-tumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 0843US2022323454A1Phenothiazines and their derivatives for use as a medicamentGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 0941US2019183948A1Use of bcl-xl inhibitor and oncolytic virus in preparation of antitumor drugGUANGZHOU VIROTECH PHARMACEUTICAL CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GUANGZHOU VIROTECH PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →